Ensysce Biosciences (ENSC) Enterprise Value (2020 - 2025)
Historic Enterprise Value for Ensysce Biosciences (ENSC) over the last 6 years, with Q3 2025 value amounting to -$2.0 million.
- Ensysce Biosciences' Enterprise Value rose 5533.62% to -$2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.0 million, marking a year-over-year increase of 5533.62%. This contributed to the annual value of -$3.8 million for FY2024, which is 16381.03% down from last year.
- Latest data reveals that Ensysce Biosciences reported Enterprise Value of -$2.0 million as of Q3 2025, which was up 5533.62% from -$2.5 million recorded in Q2 2025.
- In the past 5 years, Ensysce Biosciences' Enterprise Value ranged from a high of -$1.4 million in Q2 2024 and a low of -$12.5 million during Q4 2021
- Moreover, its 5-year median value for Enterprise Value was -$3.6 million (2022), whereas its average is -$5.0 million.
- As far as peak fluctuations go, Ensysce Biosciences' Enterprise Value tumbled by 1322025.91% in 2021, and later surged by 8010.55% in 2023.
- Quarter analysis of 5 years shows Ensysce Biosciences' Enterprise Value stood at -$12.5 million in 2021, then soared by 72.4% to -$3.5 million in 2022, then surged by 58.07% to -$1.5 million in 2023, then plummeted by 163.81% to -$3.8 million in 2024, then skyrocketed by 47.74% to -$2.0 million in 2025.
- Its Enterprise Value was -$2.0 million in Q3 2025, compared to -$2.5 million in Q2 2025 and -$3.4 million in Q1 2025.